IBM stock climbs as Jefferies turns bullish and lifts target to $360
5 January 2026
1 min read

IBM stock climbs as Jefferies turns bullish and lifts target to $360

New York, Jan 5, 2026, 14:09 (EST) — Regular session

  • IBM shares rose on fresh bullish calls from Jefferies and RBC Capital.
  • Jefferies upgraded the stock to Buy and lifted its price target to $360.
  • Investors are looking ahead to IBM’s Jan. 28 earnings update for 2026 demand signals.

International Business Machines (IBM.N) shares rose 1.6% to $296.24 in afternoon trading on Monday, after Jefferies upgraded the stock and RBC Capital raised its price target. The shares traded between $293.00 and $299.18 on the day.

The upbeat calls land as Wall Street starts to reset 2026 expectations for enterprise software and spending on artificial intelligence tools. For IBM, the next test is whether its software and hybrid-cloud businesses can keep growing fast enough to justify a premium multiple.

Jefferies upgraded IBM to Buy from Hold and raised its price target — an analyst’s estimate of where a stock could trade over the next 12 months — to $360 from $300. The broker said it is repositioning its software coverage for 2026, arguing that infrastructure software should hold up better than application software early in the year. 1

Jefferies analyst Brent Thill wrote: “These moves strengthen IBM’s hybrid cloud and data platform capabilities, creating cross-sell opportunities and expanding its open-source monetization muscle.” 2

RBC Capital also lifted its price target on IBM to $350 from $300 and kept an Outperform rating, meaning it expects the stock to beat the broader market. The firm said enterprise spending appears to be stabilizing, with generative AI — systems that produce text, code or images — pushing more experimentation even as management teams stay cautious in early-2026 guidance. 3

IBM outperformed a broadly higher market on Monday. The S&P 500 proxy SPY rose about 0.8% and the Nasdaq proxy QQQ gained about 0.9%, while Oracle (ORCL.N) fell 1.0% and Adobe (ADBE.O) slipped 0.2%.

The analyst optimism also leans on IBM’s deal-led software push. IBM last month agreed to buy Confluent for $11 billion in cash, a transaction it said is expected to close by mid-2026, adding real-time data-streaming capabilities aimed at enterprise AI deployments. 4

From a chart perspective, IBM is still below its 52-week high of $324.90 and well above its 52-week low of $214.50, leaving the round-number $300 level in focus for short-term traders. 5

But the upside case depends on execution. If corporate IT budgets soften, or if AI projects fail to convert into repeatable software revenue, IBM’s software growth narrative could lose traction; regulatory delays or integration challenges around the Confluent deal would add another overhang.

Next up is IBM’s fourth-quarter earnings announcement, scheduled for Jan. 28 (preliminary date). Investors will be watching for 2026 demand commentary, software growth trends and any timeline updates on major integration work tied to pending acquisitions. 6

Stock Market Today

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Anglo American share price slips as BofA turns neutral after copper outlook cut

Anglo American share price slips as BofA turns neutral after copper outlook cut

7 February 2026
Anglo American shares closed down 0.75% at 3,435 pence Friday after BofA Global Research downgraded the miner to “neutral” and raised its price target to 3,600 pence. Anglo cut its 2026 copper production guidance and warned of continued weakness at De Beers. The company expects $200 million in charges tied to its Chile copper operations in the second half of 2025.
D-Wave Quantum stock jumps nearly 10% as options bets build ahead of CES 2026
Previous Story

D-Wave Quantum stock jumps nearly 10% as options bets build ahead of CES 2026

Wave Life Sciences stock drops 8% as JPM Healthcare Conference looms; obesity data in focus
Next Story

Wave Life Sciences stock drops 8% as JPM Healthcare Conference looms; obesity data in focus

Go toTop